Revenue
attach_money216M USD
YoY +8.7%
VNDAVanda Pharmaceuticals Inc.$ --
Vanda Pharmaceuticals Inc.
VNDA
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-151M USD
YoY -271.8%
Net Income
verified-220M USD
YoY -1066.5%
EPS
pie_chart-3.74USD
YoY -1068.8%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress153.7%On Track
Revenue Progress216.1M
Revenue Forecast218.3M
Net Income Progress-220.5M
Net Income Forecast-143.4M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.